Literature DB >> 30145933

Stabilizing Transthyretin to Treat ATTR Cardiomyopathy.

C Cristina Quarta1, Scott D Solomon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30145933     DOI： 10.1056/NEJMe1810074

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Highlights from the 2018 European Society of Cardiology Congress in Munich, Germany.

Authors:  Dylan L Steen
Journal:  J Thromb Thrombolysis       Date:  2019-02       Impact factor: 2.300

2.  Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States.

Authors:  Tiffany P Quock; Tingjian Yan; Ryan Tieu; Anita D'Souza; Michael S Broder
Journal:  Clinicoecon Outcomes Res       Date:  2019-07-15

3.  Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD.

Authors:  Xabier Rios; Vanessa Gómez-Vallejo; Abraham Martín; Unai Cossío; Miguel Ángel Morcillo; Mobina Alemi; Isabel Cardoso; Jordi Quintana; Jesús Jiménez-Barbero; Ellen Y Cotrina; Gregorio Valencia; Gemma Arsequell; Jordi Llop
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.